“Schizophrenia sufferers are frequently pushed to the fringes of society, haunted by the delusions and hallucinations that define the worst flare-ups of the illness, while poorly served by a choice of old and imperfect treatments. In the US, they are vastly over-represented in the jobless, homeless and prison populations.

Now hope is at hand. If approved by regulators at the US Food and Drug Administration later this month, the experimental drug, known as KarXT, a twice daily pill, will arguably be the first truly novel treatment for schizophrenia in more than seven decades.”

From Financial Times.